Back
Tempest Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
10
TPST
Tempest Therapeutics, Inc.
Last Price:
$3.11
Seasonality Move:
-3.21%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TPST is experiencing slight buying pressure.
Tempest Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.04 | Buy |
| 20-day SMA: | 3.19 | Sell |
| 50-day SMA: | 7.14 | Sell |
| 200-day SMA: | 8.04 | Sell |
| 8-day EMA: | 1.6 | Buy |
| 20-day EMA: | 0.78 | Buy |
| 50-day EMA: | 0.34 | Buy |
| 200-day EMA: | 0.09 | Buy |
Tempest Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 29.08 | Sell |
| Chaikin Money Flow: | 45262 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.03 - 5.97) | Sell |
| Bollinger Bands (100): | (5.52 - 11.3) | Sell |
Tempest Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Tempest Therapeutics, Inc. Stock
Is Tempest Therapeutics, Inc. Stock a Buy?
-
Tempest Therapeutics, Inc. share price is 3.12 while TPST 8-day simple moving average is 3.04, which is a Buy signal.
-
The stock price of TPST is 3.12 while Tempest Therapeutics, Inc. 20-day SMA is 3.19, which makes it a Sell.
-
Tempest Therapeutics, Inc. 50-day simple moving average is 7.14 while TPST share price is 3.12, making it a Sell technically.
-
TPST stock price is 3.12 and Tempest Therapeutics, Inc. 200-day simple moving average is 8.04, creating a Sell signal.
TPST Technical Analysis vs Fundamental Analysis
Sell
10
Tempest Therapeutics, Inc. (TPST)
is a Sell
Is Tempest Therapeutics, Inc. a Buy or a Sell?
-
Tempest Therapeutics, Inc. stock is rated a SellThe current Tempest Therapeutics, Inc. [TPST] share price is $3.12. The Score for TPST is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Tempest Therapeutics, Inc. Stock Info
Market Cap:
11.5M
Price in USD:
3.12
Share Volume:
135.8K
Tempest Therapeutics, Inc. 52-Week Range
52-Week High:
13.65
52-Week Low:
2.87
Sell
10
Tempest Therapeutics, Inc. (TPST)
is a Sell
Tempest Therapeutics, Inc. Share Price Forecast
-
What is the Tempest Therapeutics, Inc. stock price today?The Tempest Therapeutics, Inc. stock price is 3.12 USD today.
-
Will TPST stock go up or go down?Tempest Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Tempest Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Tempest Therapeutics, Inc. is overvalued.
Is Tempest Therapeutics, Inc. Stock a Buy?
-
Tempest Therapeutics, Inc. share price is 3.12 while TPST 8-day exponential moving average is 1.60, which is a Buy signal.
-
The stock price of TPST is 3.12 while Tempest Therapeutics, Inc. 20-day EMA is 0.78, which makes it a Buy.
-
Tempest Therapeutics, Inc. 50-day exponential moving average is 0.34 while TPST share price is 3.12, making it a Buy technically.
-
TPST stock price is 3.12 and Tempest Therapeutics, Inc. 200-day simple moving average is 0.09, creating a Buy signal.
Fundamental Analysis of Tempest Therapeutics, Inc.
Is Tempest Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.76 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.17 per share, and a decrease next year of $14.10 per share.
Technical Analysis of Tempest Therapeutics, Inc.
Should I short Tempest Therapeutics, Inc. stock?
-
TPST Moving Average Covergence Divergence (MACD) indicator is 0.57, suggesting Tempest Therapeutics, Inc. is a Buy
-
Tempest Therapeutics, Inc. Relative Strength Index (RSI) is 29.08, which suggest Tempest Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Tempest Therapeutics, Inc. is (2.03 - 5.97), which suggest Tempest Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Tempest Therapeutics, Inc. is (5.52 - 11.3), which suggest Tempest Therapeutics, Inc. is a Sell
* Tempest Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.